glp 1 gip and glucagon LY3437943, a novel triple glucagon, GIP, GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Frontiers | Mechanisms of action
Description
Boost GLP-1 levels by over 50% to promote satiety and feelings of fullness
Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar
Buford debunks some of the most common myths associated with GLP-1 agonists for weight loss
GLP-1 medications are used to promote weight loss
GLP-1 receptor agonists including semaglutide must be stopped before pregnancy due to animal studies showing potential fetal harm
A study linking statins, the microbiome, and blood sugar control doesnt change clinical practice
